Express News | Danaher Appoints Julie Sawyer Montgomery to Executive Vice President for Diagnostics
Danaher: Montgomery Currently Vice Pres and Group Executive of Clinical Diagnostics Businesses >DHR
Danaher: Montgomery Currently Vice Pres and Group Executive of Clinical Diagnostics Businesses >DHR
RGIA: "Danaher Corporation (DHR): Purity in the Crown Jewel of Bioprocessing"
Here's Why Hold Strategy Is Apt for Danaher (DHR) Stock Now
Danaher on Pace for Largest Percent Decrease Since April 2023 -- Data Talk
Danaher Corporation (DHR) is currently at $252.81, down $11.80 or 4.46% --Would be lowest close since May 30, 2024, when it closed at $252.74 --On pace for largest percent decrease since April 25, 2
Danaher Unusual Options Activity For June 13
Whales with a lot of money to spend have taken a noticeably bearish stance on Danaher.Looking at options history for Danaher (NYSE:DHR) we detected 38 trades.If we consider the specifics of each trade
Peering Into Danaher's Recent Short Interest
Danaher's (NYSE:DHR) short percent of float has risen 18.68% since its last report. The company recently reported that it has 7.12 million shares sold short, which is 1.08% of all regular shares that
Is Danaher Corp (NYSE:DHR) the Best Undervalued Stock Pick of Billionaire Paul Tudor Jones?
Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics 2024-2029, With Profiles of Leading Market Players, Including Abbott, Danaher (Cepheid), Roche, Thermo-Fisher Scientific and QIAGEN - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics 2024-2029" report has been added to ResearchAndMarkets.com's offering.The global market for polymerase
Express News | Integrated DNA Technologies: New Primers and Probe Set to Identify H5N1 Avian Influenza
Dan Loeb Likes This Growth Stock
Is Now The Time To Look At Buying Danaher Corporation (NYSE:DHR)?
Today we're going to take a look at the well-established Danaher Corporation (NYSE:DHR). The company's stock saw a double-digit share price rise of over 10% in the past couple of months on the NYSE
Danaher Appoints Martin Stumpe to New Role of Chief Data & Artificial Intelligence Officer
Move reflects increasing investment in AI as driving force for innovation and productivity.Company will host Innovation Summit in December focused on AI in R&D.WASHINGTON, June 5, 2024 /PRNewswire/ --
Here's How Much You Would Have Made Owning Danaher Stock In The Last 10 Years
Danaher (NYSE:DHR) has outperformed the market over the past 10 years by 6.69% on an annualized basis producing an average annual return of 17.08%. Currently, Danaher has a market capitalization of $1
Jefferies Maintains Danaher(DHR.US) With Buy Rating, Raises Target Price to $295
Jefferies analyst Brandon Couillard maintains $Danaher(DHR.US)$ with a buy rating, and adjusts the target price from $281 to $295.According to TipRanks data, the analyst has a success rate of 63.2% an
Express News | NYSE Order Imbalance 55019.0 Shares on Sell Side
What the Options Market Tells Us About Danaher
Investors with a lot of money to spend have taken a bearish stance on Danaher (NYSE:DHR).And retail traders should know.We noticed this today when the trades showed up on publicly available options hi
The SCIEX 7500+ System Launches at ASMS 2024
FRAMINGHAM, Mass.--(BUSINESS WIRE)--#7500plus--At ASMS 2024, SCIEX, a global leader in life science analytical technologies, launches the SCIEX 7500+ system, the newest mass spectrometer in the SCIEX
SCIEX and Mass Analytica Collaborate to Advance Artificial Intelligence Quantitation Software
FRAMINGHAM, Mass.--(BUSINESS WIRE)--#AIquant--At ASMS 2024, SCIEX, a global leader in life science analytical technologies, in collaboration with Mass Analytica, presents artificial intelligence quant
Express News | NYSE Order Imbalance 315927.0 Shares on Buy Side
No Data